Granix Injection, Solution
Product Images NDC 63459-918

Product Visual Gallery

This gallery contains 57 technical images submitted to the FDA as part of the official labeling for Granix (NDC 63459-918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cephalon, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Needle Image 1 (Image 1)

An instructional diagram of a syringe for GRANIX (tbo-filgrastim) injection solution showing labeled parts including the needle guard device, needle shield, syringe barrel, finger flange, and plunger used for subcutaneous administration.*

FDA Label Image

Needle Image 2 (Image 2)

A black and white line drawing illustration showing a hand holding an injection device. The image depicts the correct grip and orientation for administering a subcutaneous injection, likely related to GRANIX (tbo-filgrastim) injection solution.*

FDA Label Image

Needle Image 3 (Image 3)

Illustration showing the administration of an injection. A hand holds a syringe with a needle inserted into the forearm of another arm, demonstrating subcutaneous injection technique.*

FDA Label Image

Needle Image 4 (Image 4)

A black and white instructional illustration showing a hand holding a syringe poised above a forearm. The image depicts a subcutaneous injection technique, with an arrow indicating the upward motion of the syringe as the needle is inserted into the skin.*

FDA Label Image

Needle Image 5 (Image 5)

An instructional line drawing showing a hand holding a prefilled syringe labeled GRANIX, with an arrow indicating the direction to pull or remove a component from the syringe. The illustration likely depicts part of the process for preparing or administering the tbo-filgrastim injection subcutaneously.*

FDA Label Image

Needleimage 6 (Image 6)

An instructional illustration showing a hand holding a syringe or pen device over a biohazard sharps disposal container, demonstrating safe injection device disposal.*

FDA Label Image

Teva Logo (Image 7)

FDA Label Image

Teva Logo (Image 8)

FDA Label Image

1 (Image 9)

An instructional diagram showing dosing and syringe use for GRANIX (tbo-filgrastim) injection solution. It specifies doses of 0.1 mL to 0.5 mL use 1 syringe, 0.1 mL to 0.8 mL require 1 syringe, and 0.9 mL to 1.6 mL require 2 syringes. The diagram includes a note about medication overfill and the need to remove air to match prescribed doses.*

FDA Label Image

Ifu Image 2 (Image 10)

An instructional diagram of a syringe used for GRANIX injection. The labeled parts include the needle cap, needle, syringe body, dose scale, label, plunger, and thumb pad, illustrating the components of the subcutaneous injection device for tbo-filgrastim.*

FDA Label Image

Ifu Image 3 (Image 11)

An instructional calendar illustration showing days of the week from Sunday to Saturday, with check marks on Sunday through Thursday. Friday is circled and highlighted with an arrow, indicating a one-time daily event for that day.*

FDA Label Image

Ifu Image 4 (Image 12)

An instructional illustration showing a hand holding a white rectangular box labeled 'Drug Name For Subcutaneous Use Only' and placing it into a black storage compartment or refrigerator with a door open, indicating proper storage or handling guidance for the injection product.*

FDA Label Image

Ifu Image 5-new (Image 13)

A dosing calculation table for GRANIX (tbo-filgrastim) injection solution showing 1st and 2nd injection amounts in milliliters across various dose volumes from 0.1 mL to 1.6 mL. The table helps determine whether one or two injections are needed for the prescribed dose.*

FDA Label Image

1 (Image 14)

An instructional diagram showing a syringe filled to 0.8 mL plus an additional 0.2 mL to total 1.0 mL volume. The image depicts the syringe barrel with volume markings and a needle attached, illustrating the correct measurement for drawing or administering the full dose.*

FDA Label Image

1 (Image 15)

Illustration showing syringe dosage fill lines for volumes from 0.1 mL to 0.8 mL on two different syringe labels. It includes a close-up demonstrating how to align the top edge of the stopper to the 0.8 mL dosage fill line for accurate dosing.*

FDA Label Image

Ifu Image 8 (Image 16)

An instructional diagram showing a syringe stopper with a focus on the top edge fill line located on the dome of the syringe stopper. The illustration highlights the fill line position relative to the syringe components.*

FDA Label Image

Ifu Image 9 (Image 17)

An instructional diagram showing stopper alignment in prefilled syringes for GRANIX (tbo-filgrastim) injection. It displays two syringe examples indicating proper stopper positions for 0.7 mL and 0.3 mL dosages, respectively, with graduated measurement markings on the syringes.*

FDA Label Image

1 (Image 18)

An instructional diagram showing items for subcutaneous injection with GRANIX syringe. Included are a gauze pad or cotton ball, an alcohol swab, a paper towel, and a biohazard-labeled sharps container for safe disposal.*

FDA Label Image

Ifu Image 11 (Image 19)

An instructional illustration showing a hand holding a rectangular box labeled for subcutaneous injection. An arrow points from this box towards an open refrigerator, indicating that the product should be stored inside the refrigerator.*

FDA Label Image

Ifu Image 12 (Image 20)

The image shows a white and blue medication carton labeled for subcutaneous use only. The packaging likely corresponds to GRANIX (tbo-filgrastim) injection, solution. The box design features a blue section on the left and an eye graphic pointing to the subcutaneous administration indication, emphasizing it is not for ocular use.*

FDA Label Image

1 (Image 21)

An instructional illustration showing dosing guidance for GRANIX (tbo-filgrastim) injection by subcutaneous route. It depicts the number of syringes to use based on dose volume: one syringe for doses from 0.1 mL to 0.5 mL or 0.1 mL to 0.8 mL, and two syringes for doses from 0.9 mL to 1.6 mL.*

FDA Label Image

Ifu Image 14 (Image 22)

Illustration showing a hand removing a prefilled syringe from a box containing four syringes. The image includes an arrow pointing upward and a red instruction to continue to the next page for the injection procedure.*

FDA Label Image

Ifu Image 15 (Image 23)

An instructional illustration showing a hand holding a prefilled syringe labeled GRANIX, an injection solution of tbo-filgrastim. The image indicates the proper injection site on the body, specifically the area just below the eye, connected with dotted lines to the syringe tip for subcutaneous administration.*

FDA Label Image

Ifu Image 16 (Image 24)

An instructional diagram showing a syringe placed on a table on the left and a stopwatch on the right indicating to wait 30 minutes, suggesting a preparation or waiting step for a subcutaneous injection.*

FDA Label Image

Ifu Image 17 (Image 25)

An illustration showing a pair of hands being washed under running water from a faucet, demonstrating proper handwashing technique.*

FDA Label Image

1 (Image 26)

Illustration showing recommended subcutaneous injection sites for GRANIX (tbo-filgrastim) injection. The diagram includes body front and back views with shaded areas indicating suitable injection sites on the upper arms, abdomen, upper thighs, upper buttocks, and shoulder blade areas.*

FDA Label Image

Ifu Image 19 (Image 27)

An instructional illustration showing a hand holding a cotton ball or pad pressing on an area of skin, likely representing part of an injection site preparation or post-injection care step.*

FDA Label Image

Ifu Image 20 (Image 28)

An instructional diagram showing two hands preparing a syringe; one hand holds the syringe and is pulling a plunger, while the other hand holds a vial caps removed and lifted upward, indicating vial access or medicine withdrawal steps for injection preparation.*

FDA Label Image

Ifu Image 21 (Image 29)

An instructional illustration showing a pair of hands holding a syringe. One hand holds the syringe barrel while the other hand adjusts the plunger, demonstrating how to prepare the syringe for injection. No text or product branding is visible.*

FDA Label Image

Ifu Image 22 (Image 30)

An instructional illustration showing a hand holding a syringe with a needle, demonstrating to slowly adjust the plunger. An inset highlights a droplet emerging from the needle tip, indicating priming or air bubble removal prior to injection.*

FDA Label Image

1 (Image 31)

An instructional illustration showing how to measure and adjust the dose of GRANIX (tbo-filgrastim) injection solution using a syringe. The image highlights the top edge (fill line) on the syringe barrel for accurate dosing between 0.5 mL and 1.6 mL. Additional text guidance explains that doses above 0.8 mL require using two syringes and provides steps to avoid air bubbles and ensure proper dosing.*

FDA Label Image

Ifu Image 24 (Image 32)

An instructional illustration showing a hand pinching the skin firmly, indicating proper technique likely related to subcutaneous injection administration.*

FDA Label Image

Ifu Image 25 (Image 33)

Instructional illustration showing the proper subcutaneous injection angle for GRANIX (tbo-filgrastim) injection. The image depicts a hand holding a syringe inserted into the skin at a 45-to-90 degree angle, indicating the acceptable range for subcutaneous administration.*

FDA Label Image

Ifu Image 26 (Image 34)

Instructional illustration showing hands administering a subcutaneous injection with GRANIX (tbo-filgrastim) prefilled syringe. One panel shows inserting the needle into the skin, and the other instructs to push the plunger all the way down to deliver the dose.*

FDA Label Image

Ifu Image 27 (Image 35)

An instructional illustration showing hands being washed under a running faucet with water flowing over them, emphasizing hand hygiene procedure.*

FDA Label Image

Ifu Image 28 (Image 36)

An instructional diagram illustrating dosing examples for a 1.1 mL dose using two syringes filled with liquid. The first syringe on the left is labeled 0.8 mL, marked with graduations from 0.1 to 0.8 mL, and the second syringe on the right is labeled 0.3 mL with graduations from 0.1 to 0.3 mL. The image depicts syringe measurement markings and fluid levels to guide dosing volume.*

FDA Label Image

1 (Image 37)

A troubleshooting instruction panel advising patients to contact their healthcare professional if they encounter problems performing the procedure. The header is in a red box labeled 'TROUBLESHOOTING' with black text below providing the guidance.*

FDA Label Image

Figure A (Image 38)

FDA Label Image

Figure B (Image 39)

An instructional illustration showing components related to injection preparation and disposal for GRANIX (tbo-filgrastim) injection. It includes labeled images of a vial, a disposable syringe with parts identified (needle, needle cap, dose scale, syringe body, label, plunger, thumb pad), a gauze pad or cotton ball, an alcohol swab, and a red sharps container for safe disposal.*

FDA Label Image

Figure C (Image 40)

An instructional illustration showing two steps of handling a vial for injection: the first step depicts a hand holding the vial, and the second step shows a hand cleaning the top of the vial with a swab. The figure is labeled as Figure B.*

FDA Label Image

Figure D (Image 41)

An instructional illustration showing a hand pulling the cap off a syringe, indicating preparation for administration of an injection. The image is labeled as 'Figure C' and is relevant to subcutaneous injection procedures.*

FDA Label Image

Figure E (Image 42)

An instructional illustration labeled Figure D showing a hand holding a vial while another hand inserts a syringe needle into the vial stopper. An arrow indicates the downward motion of the syringe needle during the medication drawing process.*

FDA Label Image

Figure F (Image 43)

Illustration showing a pair of hands preparing an injection. One hand holds a vial upside down, while the other hand draws liquid into a syringe from the vial, depicting a step in medication preparation or administration.*

FDA Label Image

Figure G (Image 44)

An instructional illustration depicts a hand drawing medication from a vial into a syringe, demonstrating proper technique for preparing an injection, labeled as Figure F.*

FDA Label Image

1 (Image 45)

An instructional illustration labeled Figure G showing a syringe held horizontally at the edge of a table with the needle pointing downward off the edge. A vial is attached to the syringe, illustrating a step likely related to preparing or administering an injection.*

FDA Label Image

Figure I (Image 46)

An instructional diagram showing recommended subcutaneous injection sites for GRANIX (tbo-filgrastim). The body front highlights the stomach area (abdomen), thighs, and buttocks, while the body back highlights the upper arm, buttocks, and thighs as injection locations.*

FDA Label Image

Figure J (Image 47)

An instructional illustration labeled Figure 1 showing a hand applying a cotton pad or swab to a dotted circle area on a forearm, indicating preparation of the skin surface before injection.*

FDA Label Image

Figure K (Image 48)

An instructional illustration showing how to pinch skin firmly, likely for an injection. The image depicts a hand pinching the skin on an arm, with arrows and text indicating to "PINCH" and hold it "FIRMLY." This is consistent with subcutaneous injection technique.*

FDA Label Image

Figure L (Image 49)

Instructional diagram showing the correct technique for subcutaneous injection at a 45-to-90 degree angle. The image depicts a hand holding a syringe injecting into the forearm, illustrating proper needle insertion angle for the administration of injection solutions such as GRANIX (tbo-filgrastim).*

FDA Label Image

Figure M (Image 50)

An instructional illustration showing hands holding a syringe labeled GRANIX, demonstrating the step to push the plunger all the way down. The image emphasizes proper injection technique for the subcutaneous injection of GRANIX solution.*

FDA Label Image

Teva Logo (Image 51)

Illustration showing hands being washed under running water from a faucet, depicting a handwashing procedure to maintain hygiene before medication preparation or administration.*

FDA Label Image

300mcg/0.5ml 1 Hcp (Image 52)

FDA Label Image

300mcg/0.5ml 1 Carton (Image 53)

The packaging label for Granix (tbo-filgrastim) Injection, 300 mcg/0.5 mL, an injectable solution for subcutaneous use. The label specifies a single-dose prefilled syringe with a safety needle guard. It is labeled for healthcare professional use only and is manufactured by UAB Teva Baltics, distributed by Teva Pharmaceuticals USA, Inc. The label includes the NDC 63459-910-11 and features the Teva logo.*

FDA Label Image

480mcg/0.8ml 1 Hcp (Image 54)

GRANIX (tbo-filgrastim) 300 mcg/0.5 mL injection, solution in a single-dose prefilled syringe for subcutaneous use by Cephalon, LLC. The label shows dosage strength, route, storage instructions at 2°C to 8°C, and indicates single use without a safety needle guard. Distributed by Teva Pharmaceuticals.*

FDA Label Image

480mcg/0.8ml 1 Home (Image 55)

Granix (tbo-filgrastim) Injection 480 mcg/0.8 mL subcutaneous solution in a single-dose prefilled syringe with safety needle guard. The label indicates it is for healthcare professional use only, manufactured by UAB Teva Baltics, and distributed by Teva Pharmaceuticals USA, Inc. The packaging contains one syringe and includes dosing and disposal information.*

FDA Label Image

300mcg/ml 10 Vial Carton (Image 56)

Granix (tbo-filgrastim) Injection 480 mcg/0.8 mL single-dose prefilled syringe label. For subcutaneous use only, distributed by Teva Pharmaceuticals USA, manufactured by Ube Industries in Japan. The label includes storage instructions and usage warnings, highlighting it is a recombinant granulocyte colony-stimulating factor (G-CSF) injection.*

FDA Label Image

1 (Image 57)

Granix (tbo-filgrastim) Injection 300 mcg/mL vial carton label for subcutaneous use. The label indicates a 10-pack of single-dose vials containing 1 mL each. The product is manufactured by Teva and labeled by Cephalon, LLC, with visible barcodes, NDC 63459-918-59, and serialization coding area. The label features dosing and storage instructions and is identified as a human prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.